Achmea Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.4M Sell
681,687
-56,698
-8% -$950K 0.15% 164
2025
Q1
$11.3M Sell
738,385
-122,509
-14% -$1.88M 0.17% 153
2024
Q4
$19M Buy
860,894
+286,371
+50% +$6.31M 0.31% 77
2024
Q3
$10.4M Sell
574,523
-12,665
-2% -$228K 0.17% 151
2024
Q2
$9.54M Buy
587,188
+26,051
+5% +$423K 0.17% 146
2024
Q1
$7.92M Hold
561,137
0.15% 162
2023
Q4
$5.86M Buy
561,137
+250,413
+81% +$2.61M 0.12% 195
2023
Q3
$3.17M Buy
310,724
+101,702
+49% +$1.04M 0.07% 267
2023
Q2
$1.57M Buy
209,022
+107,097
+105% +$806K 0.03% 372
2023
Q1
$902K Buy
101,925
+15,857
+18% +$140K 0.03% 402
2022
Q4
$735K Buy
86,068
+12,816
+17% +$109K 0.02% 440
2022
Q3
$591K Hold
73,252
0.02% 464
2022
Q2
$551K Hold
73,252
0.02% 479
2022
Q1
$688K Buy
+73,252
New +$688K 0.02% 497
2021
Q4
Hold
0
599
2021
Q3
Hold
0
647
2021
Q1
Sell
-263,146
Closed -$2.54M 513
2020
Q4
$2.54M Buy
263,146
+29,438
+13% +$284K 0.09% 267
2020
Q3
$2.11M Buy
+233,708
New +$2.11M 0.09% 257
2020
Q1
Sell
-57,044
Closed -$559K 523
2019
Q4
$559K Buy
+57,044
New +$559K 0.02% 437
2019
Q3
Sell
-121,752
Closed -$1.12M 521
2019
Q2
$1.12M Sell
121,752
-30,380
-20% -$280K 0.04% 366
2019
Q1
$2.39M Buy
152,132
+15,613
+11% +$245K 0.1% 221
2018
Q4
$2.11M Buy
136,519
+88,405
+184% +$1.36M 0.1% 221
2018
Q3
$1.04M Hold
48,114
0.04% 361
2018
Q2
$1.17M Hold
48,114
0.04% 346
2018
Q1
$822K Hold
48,114
0.03% 401
2017
Q4
$911K Buy
48,114
+26,680
+124% +$505K 0.03% 388
2017
Q3
$377K Hold
21,434
0.02% 425
2017
Q2
$712K Hold
21,434
0.04% 368
2017
Q1
$688K Buy
+21,434
New +$688K 0.03% 409